Table 1.
Characteristics of the participating sites (N = 71)
| N (%) | |
|---|---|
| Type of setting | |
| NGO/CBO | 66 (92.96) |
| Coalition of NGOs/umbrella organisation for NGOs | 3 (4.23) |
| Harm reduction sites | 1 (1.41) |
| Not reported | 1 (1.41) |
| Infections tested for | |
| HIV | 69 (97.18) |
| Hepatitis B | 30 (42.25) |
| Hepatitis C | 51 (71.83) |
| Syphilis | 52 (73.24) |
| Chlamydia | 22 (30.99) |
| Gonorrhoea | 23 (32.39) |
| Population served | |
| Gay, bisexual and other men who have sex with men | 51 (71.83) |
| People living with HIV | 41 (57.75) |
| Young people | 34 (47.89) |
| General population | 32 (45.07) |
| Transgender people | 30 (42.25) |
| Sex workers | 30 (42.25) |
| People who inject drugs | 30 (42.25) |
| Migrants | 29 (40.85) |
| Other | 3 (4.23) |
| Services offered | |
| Social support | 55 (77.46) |
| Referral/support in linkage to care or confirmatory testing | 55 (77.46) |
| Remote consultations (phone or email) | 49 (69.01) |
| Mental health support | 45 (63.38) |
| Self-testing (offering or referring) | 26 (36.62) |
| Needle and syringe exchange | 23 (32.39) |
| PrEP (initiation, provision or monitoring) | 20 (28.17) |
| Partner notification | 16 (22.54) |
| Home-based sampling | 5 (7.04) |
| Opioid substitution therapy | 4 (5.63) |
| Other | 15 (21.13) |
| Movement restrictions imposed that could affect service access | |
| Yes | 70 (98.59) |
| No | 1 (1.41) |
| Type of lockdown or social restrictionsa | |
| Mandatory ‘stay-at-home’ orders for the general population | 46 (65.71) |
| Recommended/optional ‘stay-at-home’ orders for the general population | 52 (74.29) |
| Optional ‘stay-at-home’ recommendations for risk groups or vulnerable populations | 37 (52.86) |
| Closure of public spaces | 48 (68.57) |
Notes: NGO: non-governmental organisation; CBO: community-based organisation; HIV: Human immunodeficiency syndrome; PrEP: pre-exposition prophylaxis.
a
Each respondent could indicate more than one reason or new measure, hence the totals per column is higher than the number of respondents.